| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/09/2009 | CN101525359A Hydroxypropyl isoquercitrin, hydroxypropyl isoquercitrin derivative and preparation method thereof |
| 09/09/2009 | CN101524545A Hemostatic gel suppository |
| 09/09/2009 | CN101524544A Composite gel film agent |
| 09/09/2009 | CN101524543A Hemostatic gel film agent |
| 09/09/2009 | CN101524527A TAT-HOXB4H fusion protein used as hematopoiesis irritant and the pharmaceutical composition thereof |
| 09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
| 09/09/2009 | CN101524490A Chinese medicinal composition for treating anemia and preparation method thereof |
| 09/09/2009 | CN101524437A Chinese medicinal composition for treating female anemia and preparation method thereof |
| 09/09/2009 | CN101524429A Gel film agent for treating eczema, ecthyma, and impetigo |
| 09/09/2009 | CN101524428A Gel paste for treating eczema, ecthyma, and impetigo |
| 09/09/2009 | CN101524395A Chinese medicine preparation Chinese tallow tree root-bark extract for curing hemorrhagic gastritis and application thereof |
| 09/09/2009 | CN101524378A Anti-ageing traditional Chinese medicine preparation |
| 09/09/2009 | CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite |
| 09/09/2009 | CN100537770C Von willebrand factor (vWF)-cleaving enzyme |
| 09/09/2009 | CN100537598C Substantially crystalline form of melagatran |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | USRE40911 Canine erythropoietin gene and recombinant protein |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | US7585642 Methods for evaluating the quality of a heparin sample |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
| 09/08/2009 | CA2353865C Therapeutic agents for hyperammonemia |
| 09/08/2009 | CA2287558C Heterocyclic derivatives and their use as antithrombotic agents |
| 09/08/2009 | CA2210872C Dried composition |
| 09/03/2009 | WO2009108806A1 Conjugated factor viii molecules |
| 09/03/2009 | WO2009023777A3 Methods for treating immune thrombocytopenia |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221637 Solid-state salt argatroban formulations and methods for producing and using the same |
| 09/03/2009 | US20090221636 Argatroban formulations and methods for making and using same |
| 09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 09/03/2009 | US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 09/03/2009 | US20090221510 Erythropoietin receptor peptide formulations and uses |
| 09/03/2009 | US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals |
| 09/03/2009 | US20090221480 Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof |
| 09/03/2009 | US20090220506 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 09/03/2009 | CA2716798A1 Tetrahydrofuropyridones |
| 09/03/2009 | CA2715465A1 Conjugated factor viii molecules |
| 09/03/2009 | CA2714111A1 Tetrahydro-1h-pyrrolo fused pyridones |
| 09/03/2009 | CA2712583A1 Tetrahydrothieno pyridines |
| 09/02/2009 | EP2094727A2 Laminin binding site |
| 09/02/2009 | EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 09/02/2009 | EP1761274B1 Factor viia or factor viia equivalents for preventing or attentuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) |
| 09/02/2009 | EP1478365B1 Combination consisting of trapidil and 5ht2-serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1432718B1 Phosphor containing compounds with antithrombitic activity |
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | CN101519429A Solid phase method for synchronizing Argatroban |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518644A Application of Ang-2 and genes thereof in pharmacy |
| 09/02/2009 | CN101518624A Purple millet artificial blood |
| 09/02/2009 | CN101518617A Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same |
| 09/02/2009 | CN101518606A Medicament for curing chronic aplastic anemia and preparation method thereof |
| 09/02/2009 | CN101518563A Non-oral preparation of pachyrhizua angulatus total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518562A Non-oral preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518510A Method for preparing tanshinone micelle |
| 09/02/2009 | CN101518325A Edible health-care salt and method for preparing same |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534534C Method for improving oxygen transport by stored red blood cells |
| 09/02/2009 | CN100534528C Pharmaceutical combination of G-CSF and PLGF useful for blood stem cell |
| 09/02/2009 | CN100534452C Fresh motherwort tablet and preparation method thereof |
| 09/02/2009 | CN100534438C Difructose anhydride-containing composition and use thereof |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582665 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582630 N-[3-(trifluoromethyl)phenyl]-4-{2-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-b]pyridazin-3-yl}pyrimidin-2-amine; enzyme inhibitors; inhibition/antagonism of protein kinases, glycogen synthase kinase-3-beta; central nervous system disorders; Alzheimer's disease; bipolar disorder; stroke; anticarcinogenic |
| 09/01/2009 | US7582602 Hirulog-like peptide and gene therapy |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | CA2403977C .gamma.-tocotrienol-containing diuretics |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009105231A1 Compositions and methods for treating vascular disorders |
| 08/27/2009 | WO2009105164A2 Blood substitute solution |
| 08/27/2009 | WO2009104807A1 Composition for modulating stem cell growth with prostaglandins |
| 08/27/2009 | WO2009103439A1 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 08/27/2009 | WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
| 08/27/2009 | WO2009080226A3 Heterocyclic pyrazole-carboxamides as p2y12 antagonists |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215875 Methods and kits for expanding hematopoietic stem cells |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090214646 Pharmaceutical formulations containing clopidogrel |
| 08/27/2009 | US20090214564 Anti-ephrinb2 antibodies and methods using same |
| 08/27/2009 | US20090214489 Peptides and compounds that bind to a receptor |
| 08/27/2009 | CA2715634A1 Blood substitute solution |
| 08/27/2009 | CA2715486A1 Composition for modulating stem cell growth with prostaglandins |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093290A1 Thrombin mutant |
| 08/26/2009 | EP2091952A1 Pyrazolo ý3, 4 -d¨pyrimidine p38 map kinase inhibitors |
| 08/26/2009 | EP1987026B1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders |
| 08/26/2009 | EP1819693B1 Antithrombotic diamides |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |